Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Osiris Therapeutics Inc (NASDAQ:OSIR)

5.90
Delayed Data
As of 1:58pm ET
 +0.235 / +4.15%
Today’s Change
3.55
Today|||52-Week Range
7.87
+20.06%
Year-to-Date
No recent news for Osiris Therapeutics Inc.

Today’s Trading

Previous close5.66
Today’s open5.69
Day’s range5.67 - 5.94
Volume23,933
Average volume (3 months)162,224
Market cap$195.0M
Dividend yield--
Data as of 1:58pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)+78.54%
Earnings growth (this year)+260.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+146.29%
P/E ratio117.9
Price/Sales9.15
Price/Book2.32

Competitors

 Today’s
change
Today’s
% change
AUPHAurinia Pharmaceutic...-0.04-1.08%
VBIVVBI Vaccines Inc-0.08-1.66%
CYADCelyad SA+0.15+0.67%
ENZYEnzymotec Ltd-0.15-1.64%
Data as of 2:08pm ET, 02/27/2017

Financials

Last reporting dateMay 6, 2016
EPS forecast (this quarter)$0.01
Annual revenue (last year)$59.9M
Annual profit (last year)-$1.8M
Net profit margin-0.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President &
Chief Executive Officer
David A. Dresner
Chief Operating Officer
Frank D. Czworka
Corporate headquarters
Columbia, Maryland

Forecasts


Search for Jobs